Pan, Yuanming <br/><br/>
Metallothionein 2A inhibits NF-κB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection.  [electronic resource] 

 -  Journal of translational medicine  Jul 2013 
 - 173 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1479-5876 
<br/><br/><label>Standard No.: </label>10.1186/1479-5876-11-173  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Cell Line, Tumor<br/>Cyclin D1--metabolism<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>I-kappa B Proteins--metabolism<br/>Immunohistochemistry<br/>Male<br/>Metallothionein--metabolism<br/>Middle Aged<br/>NF-KappaB Inhibitor alpha<br/>NF-kappa B--metabolism<br/>Prognosis<br/>Signal Transduction<br/>Stomach Neoplasms--metabolism<br/>Treatment Outcome<br/>Up-Regulation<br/>Young Adult